STOCKHOLM, July 9, 2020
- Next generation DigniCap Delta device minimizes hair loss from chemotherapy
STOCKHOLM, July 9, 2020 /PRNewswire/ -- Dignitana AB today announces a partnership with Nuffield Health in the United Kingdom to provide DigniCap scalp cooling to minimize hair loss from chemotherapy. As the largest healthcare charity in the United Kingdom, Nuffield Health operates 31 hospitals and will initially provide DigniCap at North Staffordshire in Newcastle-under-Lyme and Wolverhampton Hospital in West Midlands, expanding to other Nuffield hospitals in the future.
"We are delighted to work with Nuffield in bringing the next generation in scalp cooling technology to their patients," said William Cronin, Chief Executive Officer of Dignitana AB. "Hair loss is a critical quality of life issue for so many cancer patients. The next generation DigniCap Delta is designed to optimize results and provide significant improvements in the patient experience. The dedicated team at Nuffield shares our commitment to these values and is eager to provide patients with access to this cutting-edge technology."
Sweden-based Dignitana is the world leader in scalp cooling innovation providing the DigniCap Scalp Cooling System in 38 countries around the globe. The CE-marked DigniCap Scalp Cooling System demonstrated a success rate of 66 percent in the pivotal trial for FDA clearance in 2015. The new DigniCap Delta device was introduced in 2019.
VP Corporate Communications
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Dignitana selected as Scalp Cooling Provider by Nuffield Health in UK
DigniCap Delta on patient